|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments for: | |||||
| Depreciation | |||||
| Impairment of intangible assets | |||||
| Share in result of an associate | |||||
| Loss / (gain) on disposal of discontinued operations | |||||
| Deferred income | |||||
| Unrealized foreign currency exchange loss/(gain), net | |||||
| Net interest expense | |||||
| Share based payments | |||||
| Transaction costs | |||||
| Employee benefits | |||||
| Revaluation loss derivative financial instruments | |||||
| Gain on modification of financial instruments | |||||
| Income tax gain | |||||
| Total | |||||
| Changes in: | |||||
| Inventories | |||||
| Trade and other receivables | |||||
| Prepayments | |||||
| Trade and other payables | |||||
| Accrued expenses | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of property and equipment | |||||
| Purchase of intangibles | |||||
| Cash received from / (paid for) other financial assets | |||||
| Investment in an associate | |||||
| Interest received | |||||
| Disposal of subsidiaries | |||||
| Net cash from / used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from offerings and warrant exercises | |||||
| Transaction costs | |||||
| Proceeds from loans | |||||
| Repayment of loan | |||||
| Repayment of lease liabilities | |||||
| Interest paid | |||||
| Net cash from financing activities | |||||
| Net increase / (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of the period | |||||
| Net effect of currency translation on cash and cash equivalents | |||||
| Cash and cash equivalents at end of the period | |||||
Loading...
